Peter Dandliker

Peter Dandliker currently serves as the Chief Operating Officer at Passkey Therapeutics, bringing with him extensive experience in the pharmaceutical and biotech industries. Prior to his current role, he held various leadership positions at Dewpoint Therapeutics, Merck, and Abbott Laboratories, where he led teams in drug discovery and research operations. With a background in organic and biophysical chemistry, Peter has a strong foundation in scientific research and project management. His expertise lies in technology development, project leadership, and external research programs.